GUERRINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 512
EU - Europa 197
AS - Asia 44
AF - Africa 8
SA - Sud America 1
Totale 762
Nazione #
US - Stati Uniti d'America 501
FR - Francia 96
IT - Italia 50
VN - Vietnam 17
DE - Germania 11
SG - Singapore 10
RU - Federazione Russa 9
IN - India 8
ZA - Sudafrica 8
CA - Canada 7
GB - Regno Unito 6
NL - Olanda 6
CN - Cina 4
CZ - Repubblica Ceca 4
FI - Finlandia 4
HN - Honduras 4
UA - Ucraina 4
RS - Serbia 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
HK - Hong Kong 1
HR - Croazia 1
ID - Indonesia 1
JP - Giappone 1
LU - Lussemburgo 1
MK - Macedonia 1
RO - Romania 1
SE - Svezia 1
TW - Taiwan 1
Totale 762
Città #
Santa Cruz 50
Fairfield 46
Seattle 43
Ashburn 35
Buffalo 29
Woodbridge 26
Houston 23
Serra 21
Paris 17
Wilmington 14
Dong Ket 13
Cambridge 12
Dallas 9
San Francisco 8
Las Vegas 7
Ann Arbor 6
Phoenix 6
San Diego 6
Muizenberg 5
Ottawa 5
Riva 5
Chicago 4
Des Moines 4
Helsinki 4
Henderson 4
Lake Forest 4
New York 4
Redmond 4
Boardman 3
Clearwater 3
Los Angeles 3
Rome 3
Amsterdam 2
Beijing 2
Belgrade 2
Bremen 2
Büdelsdorf 2
Castellammare di Stabia 2
Centro 2
Jacksonville 2
Johannesburg 2
Mountain View 2
New Kensington 2
Pisa 2
Provo 2
Pune 2
Saint Petersburg 2
San Jose 2
Tagliacozzo 2
Tappahannock 2
University Park 2
Washington 2
Atlanta 1
Austin 1
Bari 1
Bengaluru 1
Bergamo 1
Bhubaneswar 1
Bissen 1
Brierley Hill 1
Bristol 1
Capannori 1
Cassano d'Adda 1
Castiglione Chiavarese 1
Catania 1
Charlottetown 1
Chennai 1
Constanta 1
Dello 1
Elk Grove Village 1
Fort Wayne 1
Frankfurt Am Main 1
Hamilton 1
Herndon 1
Ho Chi Minh City 1
Kowloon 1
Lincoln 1
London 1
Maastricht 1
Milan 1
Milpitas 1
Moscow 1
North Bergen 1
Omaha 1
Pacific 1
Palo Alto 1
Pasadena 1
Piacenza 1
Pomezia 1
Portland 1
Potenza 1
Prague 1
Rohtak 1
Saint Louis 1
San Giuliano Terme 1
San Pedro Sula 1
Santa Clara 1
Santa Croce sull'Arno 1
Silverton 1
Southwark 1
Totale 514
Nome #
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup, file e0d6c92c-7650-fcf8-e053-d805fe0aa794 113
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study, file e0d6c929-a3e5-fcf8-e053-d805fe0aa794 96
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia, file e0d6c92d-d6ab-fcf8-e053-d805fe0aa794 91
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia, file e0d6c92b-0633-fcf8-e053-d805fe0aa794 90
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia, file e0d6c92a-fe51-fcf8-e053-d805fe0aa794 87
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients, file e0d6c92c-764e-fcf8-e053-d805fe0aa794 81
The perception of stress in cat owners, file e0d6c92b-c7b7-fcf8-e053-d805fe0aa794 64
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia, file e0d6c92c-8b28-fcf8-e053-d805fe0aa794 58
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia, file e0d6c92c-8d1b-fcf8-e053-d805fe0aa794 42
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients, file e0d6c92d-76b1-fcf8-e053-d805fe0aa794 26
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS, file e0d6c931-d4a0-fcf8-e053-d805fe0aa794 9
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS), file e0d6c931-e454-fcf8-e053-d805fe0aa794 9
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation, file e0d6c92a-88d6-fcf8-e053-d805fe0aa794 6
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial, file e0d6c92c-d75f-fcf8-e053-d805fe0aa794 6
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia, file e0d6c928-259b-fcf8-e053-d805fe0aa794 5
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia, file e0d6c929-02ff-fcf8-e053-d805fe0aa794 5
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms, file e0d6c92b-6a5f-fcf8-e053-d805fe0aa794 4
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia, file e0d6c92c-fdf1-fcf8-e053-d805fe0aa794 3
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice, file e0d6c92d-a8fc-fcf8-e053-d805fe0aa794 2
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2, file e0d6c92f-7c97-fcf8-e053-d805fe0aa794 2
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation, file e0d6c92f-b393-fcf8-e053-d805fe0aa794 2
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients, file e0d6c92f-d7e6-fcf8-e053-d805fe0aa794 2
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib, file e0d6c92f-125a-fcf8-e053-d805fe0aa794 1
Totale 804
Categoria #
all - tutte 2.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.093


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 2 5
2019/2020149 4 3 3 7 18 22 20 19 22 9 12 10
2020/2021123 9 13 2 4 6 16 9 11 14 13 9 17
2021/2022191 14 7 6 13 16 6 16 7 14 7 61 24
2022/2023145 3 7 54 22 11 10 4 3 2 7 19 3
2023/2024183 7 10 22 13 28 41 38 13 7 4 0 0
Totale 804